Pay in 4 interest-free payments of $17.25 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
and well-documented efficacy profile
a widely used anticonvulsant and nerve pain reliever
Contraindications: Active bleeding
as it may increase the risk of dizziness or fainting
It is the maximum approved strength of subcutaneous GLP-1 receptor agonist injection
Efavir 200 mg (Efavirenz) Quantity:90 Capsule/s and well-documented efficacy profileProduct Overview Efavir 200 mg is an antiretroviral medication manufactured by Cipla Limited. It is formulated as hard gelatin capsules containing 200 mg of Efavirenz, a nonnucleoside reverse transcriptase inhibitor (NNRTI). Each bottle contains 30 capsules, providing a convenient supply for ongoing HIV therapy. The product is marketed for adult patients with HIV infection who require suppressive antiviral treatment as part of a combination regimen.
